These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22843169)

  • 21. Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopenia.
    Zoller M; Atmowihardjo I; Huch J; Albrecht I; Habedank D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):624. PubMed ID: 34972517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of cross-reactivity of SR90107A/ORG31540 pentasaccharide with antibodies to heparin-PF4 complexes developed in heparin-induced thrombocytopenia.
    Amiral J; Lormeau JC; Marfaing-Koka A; Vissac AM; Wolf M; Boyer-Neumann C; Tardy B; Herbert JM; Meyer D
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):114-7. PubMed ID: 9518042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and management of heparin-induced thrombocytopenia: a consensus statement from the Thrombosis and Haemostasis Society of Australia and New Zealand HIT Writing Group.
    Joseph J; Rabbolini D; Enjeti AK; Favaloro E; Kopp MC; McRae S; Pasalic L; Tan CW; Ward CM; Chong BH
    Med J Aust; 2019 Jun; 210(11):509-516. PubMed ID: 31155728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
    Demma LJ; Winkler AM; Levy JH
    Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia: a review.
    Girolami B; Girolami A
    Semin Thromb Hemost; 2006 Nov; 32(8):803-9. PubMed ID: 17171593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
    Prechel M; Walenga JM
    Semin Thromb Hemost; 2008 Feb; 34(1):86-96. PubMed ID: 18393145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia: current status and diagnostic challenges.
    Otis SA; Zehnder JL
    Am J Hematol; 2010 Sep; 85(9):700-6. PubMed ID: 20665476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of acute systemic reaction and detection of IgG antibodies against PF4/heparin complexes in hemodialysis patients.
    Matsuo T; Wanaka K; Miyasita K; Prechel M; Walenga JM
    Thromb Res; 2012 Apr; 129(4):474-8. PubMed ID: 22088491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment.
    Kelton JG
    Chest; 2005 Feb; 127(2 Suppl):9S-20S. PubMed ID: 15706026
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heparin-induced thrombocytopenia and thrombosis. Thrombosis as an early cardinal symptom of heparin allergy].
    Folwaczny EK; Stürmer KM
    Chirurg; 2002 Dec; 73(12):1197-203. PubMed ID: 12491049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis.
    Cuker A
    Thromb Haemost; 2011 Dec; 106(6):993-4. PubMed ID: 22012630
    [No Abstract]   [Full Text] [Related]  

  • 37. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
    Matsuo T; Wanaka K; Asada R
    Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
    Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
    Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
    Whitlatch NL; Perry SL; Ortel TL
    Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-induced thrombocytopenia (HIT II) - a drug-associated autoimmune disease.
    Nowak G
    Thromb Haemost; 2009 Nov; 102(5):887-91. PubMed ID: 19888524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.